Martins focus is on advising in particular investors, hospitals, operators of medical care centers (MVZ), laboratory companies, private equity houses and digital health start-ups on all issues of regulatory health law, in particular on the licensing of medical care centers, contract physician law, professional law and digital health solutions.

In addition, Martin assits the firm in advising clients in the public sector and vis-à-vis politicians and associations. Furthermore, he is a lecturer at the Hochschule of Aalen.

Martin is a member of the Environmental Planning & Regulatory Practice Area and the Life Sciences & Healthcare Industry Group.

Show full CV Hide full CV

Latest news & insights

Life sciences & healthcare

Weed legal - German Bundestag decriminalizes cannabis consumption: What growers need to know now.

19 March 2024
Briefing

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Taylor Wessing advises Mercurius Health on the acquisition of MEDICLIN Robert Janker Klinik

6 November 2023

by multiple authors

Click here to find out more
Life sciences & healthcare

Update on cannabis legalisation: working draft of a cannabis law

25 May 2023
Briefing

by Dr. Daniel Tietjen and Dr. Martin Jäger

Click here to find out more
Patents & innovation

Where are the new regulations on cannabis going? Decriminalisation in designated cannabis clubs and hesitant liberalisation by the state

17 April 2023
Quick read

by Dr. Daniel Tietjen and Dr. Martin Jäger

Click here to find out more

Meet me at

There are no upcoming events